ArticleFrontiers in pharmacology2023

Safety, tolerability, and pharmacokinetics of TG-1000, a new molecular entity against influenza virus: first-in-human study.

Su-Mei Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.